Harpoon Therapeutics Inc expected to post a loss of 52 cents a share - Earnings Preview

Harpoon Therapeutics

03/11/2021 14:09

* Harpoon Therapeutics Inc  HARP.OQ   HARP.O  is expected
to show a rise in quarterly revenue when it reports  results 
* The South San Francisco, California-based company is expected
to report  a 61.9% increase in revenue to $6.304 million from
$3.89 million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Harpoon Therapeutics
Inc is for a loss of 52 cents per share. For the same quarter
last year, the company reported a loss of 53 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $30​, about 78% above​ its last closing
price of $6.60. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.41       -0.43      -0.52     Missed  -19.7
 Mar. 31 2021  -0.42       -0.44      -0.37     Beat    16
 Dec. 31 2020  -0.48       -0.54      -0.45     Beat    16.7​
 Sep. 30 2020  -0.47       -0.50      -0.53     Missed  -7
 ​​Jun.        -0.48       -0.47      -0.51     Missed  -7.4
 30 2020                                                
 Mar. 31 2020  -0.36       -0.41      -0.51     Missed  -23.5​
 Dec. 31 2019  -0.48       -0.53      -0.58     Missed  -9.5
 Sep. 30 2019  -0.55       -0.55      -0.65     Missed  -18.1
 This summary was machine generated November 3 at 14:09 GMT.  All
figures in US dollars unless otherwise stated